Bullish Case: CBOE at $253 is -18% from 60 days ago despite record fundamentals: 0DTE at ~61% of SPX ADV, near-1-year-low equity vol post-Jackson Hole lifting net revenue, and a ~17x 2027 multiple. Market IV (44.5% front expiry) sits ~18 points above Helium's path (26.8%/21.5%), implying overpriced fear. Both density functions peak near $257.50 with calls traded 14% more than puts; mean reversion plus cheap hedging demand favors a grind back toward $265-280.

Bearish Case: Term structure is in backwardation with steep short-dated IV (44.5% Oct 3 vs ~35% six-month), signaling event risk the market is actively paying for. Bearish risk exceeds bullish by 7%, volume is 4th percentile (brittle positioning), the Helium forecast correlation is -0.1, and 60-day momentum (-18%) shows distribution. Oil near $94 and yield-contagion episodes could re-spike VIX complex volatility—paradoxically helpful to CBOE revenue but harsh on the equity. Prediction-market expansion (sports self-certification, 88% No) is stalled.

Potential Outcomes:

• 35%: IV-rich front expiries decay; price mean-reverts to $262-275 by Nov expiries (falsified by close <$245 on 11/21).
• 25%: continued chop $245-260 as vol complex stays elevated (falsified by close outside range).
• 20%: macro/oil shock drops price to $230-245 with VIX spike (falsified if SPY vols compress).
• 12%: recovery >$285 on earnings/0DTE volume momentum (falsified if call flow fades).
• 8%: regulatory/competitive slip (self-certification denial, prediction-market competition) below $230.

September 29, 2026